Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
HIV Infection
Interventions
DRUG

LPV/RTV + 2NRTIs

Tablets, Oral, Variable, Twice daily, 48 weeks.

DRUG

LPV/RTV + 2NRTIs

Tablets, Oral, Variable, Twice daily, 48 weeks.

Trial Locations (37)

Unknown

Local Institution, Phoenix

Local Institution, Altamonte Springs

Local Institution, Fort Lauderdale

Local Institution, Vero Beach

Local Institution, Honolulu

Local Instution, Wichita

Local Instution, Lexington

Local Institution, Louisville

Local Institution, East Orange

Local Institution, Albany

Local Institution, Huntersville

Local Institution, Portland

Local Institution, Dallas

Local Institution, Buenos Aires

Local Institution, Capital Federal

Local Institution, La Plata

Local Institution, Mar del Plata

Local Institution, Córdoba

Local Institution, Rosario

Local Institution, Buenos Aires

Local Institution, Curitiba

Local Institution, Recife

Local Institution, Rio de Janeiro

Local Institution, Campinas

Local Institution, São Paulo

Local Institution, Guatemala City

Local Institution, Durango

Local Institution, Guadalajara

Local Institution, Lima

Local Institution, Port Elizabeth

Local Institution, Bloemfontein

Local Institution, Bedford Gardens

Local Institution, Johannesburg

Local Institution, Meadowdale

Local Institution, Westdene

Local Institution, Mowbray

Local Institution, Rugby

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY